Current Cardiovascular Risk Reports

, Volume 6, Issue 1, pp 1–3

Unfavorable Effects of Intensive Glucose Lowering on Mortality: Lessons from the 5-Year Follow-up of the ACCORD Trial

Clinical Trial Report
  • 55 Downloads

References

  1. 1.
    Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.PubMedCrossRefGoogle Scholar
  2. 2.
    Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364(9):818–28.PubMedCrossRefGoogle Scholar
  3. 3.
    Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–41.PubMedCrossRefGoogle Scholar
  4. 4.
    Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359(15):1565–76.PubMedCrossRefGoogle Scholar
  5. 5.
    Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.PubMedCrossRefGoogle Scholar
  6. 6.
    Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–39.PubMedCrossRefGoogle Scholar
  7. 7.
    Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009;53(3):298–304.PubMedCrossRefGoogle Scholar
  8. 8.
    Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909.PubMedCrossRefGoogle Scholar
  9. 9.
    Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, et al. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care. 2010;33(5):983–90.PubMedCrossRefGoogle Scholar
  10. 10.
    Standards of medical care in diabetes--2011. Diabetes Care 2011, 34 Suppl 1:S11–61.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Internal Medicine, Seoul National University College of MedicineSeoul National University Bundang HospitalSeoulKorea
  2. 2.General Medicine Division, Massachusetts General HospitalHarvard Medical SchoolBostonUSA
  3. 3.Cardiovascular Research Group, School of BiomedicineUniversity of ManchesterManchesterUK
  4. 4.Manchester Diabetes Centre, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research CentreCentral Manchester University Hospitals NHS Foundation TrustManchesterUnited Kingdom

Personalised recommendations